NVE Takes First Shot At Ephedra Ban: FDA Violated DSHEA, Firm Says

NVE Pharmaceuticals is challenging FDA's ban of ephedra on the grounds the agency did not meet its burden of proving the ingredient unsafe under the Dietary Supplement Health & Education Act